Acute aluminum phosphide poisoning. Toxic effect of pesticides
Conditions
Interventions
Intervention 1: Control group: Patients will receive the standard treatment, which is determined by the attending physician who maintains clinical responsibility for all patients. It consists of patie
Sponsors
Menoufia Faculty of Medicine
Eligibility
Sex/Gender
All
Age
12 Years to No maximum
Inclusion criteria
Inclusion criteria: History of taking aluminum phosphide tablet(s) and clinical manifestations of acute aluminum phosphide poisoning Reliable identification of the compound either by the container brought by patient attendants or subsequent confirmation with positive silver nitrate test on gastric sample in case of oral route exposure
Exclusion criteria
Exclusion criteria: Patients less than 12 years old Pregnant and lactating women Patients suffering from chronic diseases (e.g. diabetes mellitus, cardiovascular diseases, and hepatic or renal failure) Tablet(s) was/were dissolved in water before ingestion Ingestion of air-exposed aluminium phosphide tablets Time passed since ingestion more than 8 hours Patient who refused to participate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| All-cause mortality during hospital admission. Timepoint: At the end of the hospitalization period. Method of measurement: Clinical assessment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of patients requiring intubation. Timepoint: Before the intervention and one day after completion of the intervention. Method of measurement: Clinical evaluation.;Duration of ventilation. Timepoint: Before the intervention and one day after completion of the intervention. Method of measurement: Clinical evaluation.;Duration of hospitalization. Timepoint: At the end of the hospitalization period. Method of measurement: Clinical evaluation. | — |
Countries
Egypt
Contacts
Public ContactSoha Hamid
Menoufia University Faculty of Medicine
Outcome results
None listed